Norman Aubry

709 total citations
23 papers, 545 citations indexed

About

Norman Aubry is a scholar working on Molecular Biology, Infectious Diseases and Hepatology. According to data from OpenAlex, Norman Aubry has authored 23 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Infectious Diseases and 7 papers in Hepatology. Recurrent topics in Norman Aubry's work include HIV/AIDS drug development and treatment (9 papers), Hepatitis C virus research (7 papers) and Biochemical and Molecular Research (6 papers). Norman Aubry is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), Hepatitis C virus research (7 papers) and Biochemical and Molecular Research (6 papers). Norman Aubry collaborates with scholars based in Canada, Germany and Egypt. Norman Aubry's co-authors include Steven R. LaPlante, Pierre Bonneau, Pierre L. Beaulieu, René Coulombe, James Gillard, Robert Déziel, George Kukolj, Dale R. Cameron, Michael J. Little and Araz Jakalian and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Norman Aubry

22 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Norman Aubry Canada	14	255	162	133	129	102	23	545
John Pichardo United States	15	163 0.6×	205 1.3×	146 1.1×	153 1.2×	84 0.8×	30	458
Chantal Grand‐Maître Canada	15	308 1.2×	95 0.6×	151 1.1×	360 2.8×	56 0.5×	23	663
Kevin X. Chen United States	14	211 0.8×	210 1.3×	163 1.2×	233 1.8×	74 0.7×	23	562
Yves Bousquet Canada	13	195 0.8×	220 1.4×	211 1.6×	258 2.0×	61 0.6×	15	575
Keith F. McDaniel United States	17	281 1.1×	207 1.3×	175 1.3×	413 3.2×	41 0.4×	37	861
James Gillard Canada	19	314 1.2×	330 2.0×	273 2.1×	469 3.6×	97 1.0×	30	975
Hiromasa Hashimoto Japan	14	298 1.2×	143 0.9×	113 0.8×	409 3.2×	36 0.4×	25	828
Stefania Colarusso Italy	12	184 0.7×	295 1.8×	174 1.3×	218 1.7×	137 1.3×	16	619
Stéphane Bogen United States	17	173 0.7×	306 1.9×	233 1.8×	460 3.6×	70 0.7×	59	932
Élise Ghiro Canada	11	210 0.8×	251 1.5×	166 1.2×	258 2.0×	113 1.1×	15	582

Countries citing papers authored by Norman Aubry

Since Specialization

Citations

This map shows the geographic impact of Norman Aubry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman Aubry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman Aubry more than expected).

Fields of papers citing papers by Norman Aubry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norman Aubry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman Aubry. The network helps show where Norman Aubry may publish in the future.

Co-authorship network of co-authors of Norman Aubry

This figure shows the co-authorship network connecting the top 25 collaborators of Norman Aubry. A scholar is included among the top collaborators of Norman Aubry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norman Aubry. Norman Aubry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

França, Tanos C. C., et al.. (2023). Determining the Predominant Conformations of Mortiamides A–D in Solution Using NMR Data and Molecular Modeling Tools. ACS Omega. 8(29). 25832–25838. 1 indexed citations

2.

LaPlante, Steven R., François Bilodeau, Norman Aubry, et al.. (2013). N- versus O-alkylation: Utilizing NMR methods to establish reliable primary structure determinations for drug discovery. Bioorganic & Medicinal Chemistry Letters. 23(16). 4663–4668. 16 indexed citations

3.

Aubry, Norman, Gordon T. Bolger, Pierre Bonneau, et al.. (2013). Monitoring Drug Self-Aggregation and Potential for Promiscuity in Off-Target In Vitro Pharmacology Screens by a Practical NMR Strategy. Journal of Medicinal Chemistry. 56(17). 7073–7083. 48 indexed citations

4.

LaPlante, Steven R., Herbert Nar, Christopher T. Lemke, et al.. (2013). Ligand Bioactive Conformation Plays a Critical Role in the Design of Drugs That Target the Hepatitis C Virus NS3 Protease. Journal of Medicinal Chemistry. 57(5). 1777–1789. 36 indexed citations

5.

LaPlante, Steven R., James Gillard, Araz Jakalian, et al.. (2010). Importance of Ligand Bioactive Conformation in the Discovery of Potent Indole-Diamide Inhibitors of the Hepatitis C Virus NS5B. Journal of the American Chemical Society. 132(43). 15204–15212. 34 indexed citations

6.

Kawai, Stephen H., Norman Aubry, Jean‐Simon Duceppe, Montse Llinàs‐Brunet, & Steven R. LaPlante. (2009). Dimethylthiazolidine Carboxylic Acid as a Rigid P3 Unit in Inhibitors of Serine Proteases: Application to Two Targets^†. Chemical Biology & Drug Design. 74(5). 517–522. 2 indexed citations

7.

Little, Michael J., et al.. (2006). Quantifying trifluoroacetic acid as a counterion in drug discovery by 19F NMR and capillary electrophoresis. Journal of Pharmaceutical and Biomedical Analysis. 43(4). 1324–1330. 27 indexed citations

8.

LaPlante, Steven R., Araz Jakalian, Norman Aubry, et al.. (2004). Binding Mode Determination of Benzimidazole Inhibitors of the Hepatitis C Virus RNA Polymerase by a Structure and Dynamics Strategy. Angewandte Chemie International Edition. 43(33). 4306–4311. 45 indexed citations

9.

LaPlante, Steven R., Araz Jakalian, Norman Aubry, et al.. (2004). Binding Mode Determination of Benzimidazole Inhibitors of the Hepatitis C Virus RNA Polymerase by a Structure and Dynamics Strategy. Angewandte Chemie. 116(33). 4406–4411. 4 indexed citations

10.

LaPlante, Steven R., Norman Aubry, Pierre Bonneau, et al.. (2000). NMR line-broadening and transferred NOESY as a medicinal chemistry tool for studying inhibitors of the hepatitis C virus NS3 protease domain. Bioorganic & Medicinal Chemistry Letters. 10(20). 2271–2274. 29 indexed citations

11.

LaPlante, Steven R., Norman Aubry, Robert Déziel, Feng Ni, & Ping Xu. (2000). Transferred¹³CT₁Relaxation at Natural Isotopic Abundance: A Practical Method for Determining Site-Specific Changes in Ligand Flexibility upon Binding to a Macromolecule. Journal of the American Chemical Society. 122(50). 12530–12535. 25 indexed citations

12.

LaPlante, Steven R., Dale R. Cameron, Norman Aubry, et al.. (1999). Solution Structure of Substrate-based Ligands When Bound to Hepatitis C Virus NS3 Protease Domain. Journal of Biological Chemistry. 274(26). 18618–18624. 47 indexed citations

13.

LaPlante, Steven R., Pierre Bonneau, Norman Aubry, et al.. (1999). Characterization of the Human Cytomegalovirus Protease As an Induced-Fit Serine Protease and the Implications to the Design of Mechanism-Based Inhibitors. Journal of the American Chemical Society. 121(13). 2974–2986. 39 indexed citations

14.

LaPlante, Steven R., Dale R. Cameron, Norman Aubry, et al.. (1998). The Conformation of a Peptidyl Methyl Ketone Inhibitor Bound to the Human Cytomegalovirus Protease. Angewandte Chemie International Edition. 37(19). 2729–2732. 6 indexed citations

15.

LaPlante, Steven R., Norman Aubry, Pierre Bonneau, et al.. (1998). Human Cytomegalovirus Protease Complexes Its Substrate Recognition Sequences in an Extended Peptide Conformation^,. Biochemistry. 37(27). 9793–9801. 17 indexed citations

16.

LaPlante, Steven R., Dale R. Cameron, Norman Aubry, et al.. (1998). Die Konformation eines an die humane Cytomegalievirus-Protease gebundenen Peptidylmethylketon-Inhibitors. Angewandte Chemie. 110(19). 2858–2860. 2 indexed citations

17.

LaPlante, Steven R., Liang Tong, Norman Aubry, et al.. (1996). Several polyhydroxymonoamide renin inhibitors assume similar conformations n the unbound and renin‐bound states. International journal of peptide & protein research. 48(5). 401–410.

18.

LaPlante, Steven R., Norman Aubry, Michel Liuzzi, et al.. (1994). The critical C‐terminus of the small subunit of herpes simplex virus ribonucleotide reductase is mobile and conformationally similar to C‐terminal peptides. International journal of peptide & protein research. 44(6). 549–555. 7 indexed citations

19.

Moss, Neil, Robert Déziel, Norman Aubry, et al.. (1993). Inhibition of herpes simplex virus type 1 ribonucleotide reductase by substituted tetrapeptide derivatives. Journal of Medicinal Chemistry. 36(20). 3005–3009. 30 indexed citations

20.

Aubry, Norman, Raymond Plante, & Robert Déziel. (1990). A simple synthesis of γ and δ-keto α-amino acid derivatives. Tetrahedron Letters. 31(44). 6311–6312. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact